C-reactive protein and statins: IL-8 as a molecular link?

被引：5
作者：
Szmitko, PE
Verma, S
机构：
[1] St Michaels Hosp, Div Cardiac Surg, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, Div Gen Internal Med, Toronto, ON, Canada
来源：
CLINICAL SCIENCE | 2005年 / 108卷 / 06期
关键词：
atherosclerosis; C-reactive protein (CRP); interleukin-8; mitogen-activated protein kinase (MAPK); 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitor; statin;
D O I：
10.1042/CS20050093
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
CRP (C-reactive protein) has not only emerged as a useful biomarker for cardiovascular disease, but also as a mediator of atherosclerosis. CRP directly activates vascular endothelial cells, amplifying the inflammatory response underlying atherogenesis. The expression of IL (interleukin)-8 appears to serve as one of the downstream effects of CRP. Kibayashi and co-workers in this issue of Clinical Science confirm that CRP induces IL-8 production in human aortic endothelial cells in vitro, via the activation of MAPKs (mitogen-activated protein kinases), an effect that can be inhibited by pitavastatin.
引用
收藏
页码：493 / 495
页数：3
相关论文
共 21 条
  • [1] Increased thrombosis after arterial injury in human C-reactive protein - Transgenic mice
    Danenberg, HD
    Szalai, AJ
    Swaminathan, RV
    Peng, L
    Chen, ZP
    Seifert, P
    Fay, WP
    Simon, DI
    Edelman, ER
    [J]. CIRCULATION, 2003, 108 (05) : 512 - 515
  • [2] C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells
    Devaraj, S
    Xu, DY
    Jialal, I
    [J]. CIRCULATION, 2003, 107 (03) : 398 - 404
  • [3] Effect of C-reactive protein on chemokine expression in human aortic endothelial cells
    Devaraj, S
    Kumaresan, PR
    Jialal, I
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 36 (03) : 405 - 410
  • [4] Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells
    Khreiss, T
    József, L
    Potempa, LA
    Filep, JG
    [J]. CIRCULATION, 2004, 109 (16) : 2016 - 2022
  • [5] Inhibitory effect of pitavastatin (NK-104) on the C-reactive-protein-induced interleukin-8 production in human aortic endothelial cells
    Kibayashi, E
    Urakaze, M
    Kobashi, C
    Kishida, M
    Takata, M
    Sato, A
    Yamazaki, K
    Kobayashi, M
    [J]. CLINICAL SCIENCE, 2005, 108 (06) : 515 - 521
  • [6] C-reactive protein upregulates complement-inhibitory factors in endothelial cells
    Li, SH
    Szmitko, PE
    Weisel, RD
    Wang, CH
    Fedak, PWM
    Li, RK
    Mickle, DAG
    Verma, S
    [J]. CIRCULATION, 2004, 109 (07) : 833 - 836
  • [7] Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease
    Nissen, SE
    Tuzcu, EM
    Schoenhagen, P
    Crowe, T
    Sasiela, WJ
    Tsai, J
    Orazem, J
    Magorien, RD
    O'Shaughnessy, C
    Ganz, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (01) : 29 - 38
  • [8] C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
    Paul, A
    Ko, KWS
    Li, L
    Yechoor, V
    McCrory, MA
    Szalai, AJ
    Chan, L
    [J]. CIRCULATION, 2004, 109 (05) : 647 - 655
  • [9] Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
    Pearson, TA
    Mensah, GA
    Alexander, RW
    Anderson, JL
    Cannon, RO
    Criqui, M
    Fadl, YY
    Fortmann, SP
    Hong, Y
    Myers, GL
    Rifai, N
    Smith, SC
    Taubert, K
    Tracy, RP
    Vinicor, F
    [J]. CIRCULATION, 2003, 107 (03) : 499 - 511
  • [10] QAMIRANI E, 2005, ARTERIOSCLER THROMB
123